Advances in automation and cleanroom technology improve efficiency for small commercial quantities of aseptically filled drug products.
With the increase in drug products targeted to specific patient groups, including orphan drugs and even individualized medicine, manufacturers must consider how to optimize the manufacturing process for aseptic fill/finish of drugs in small batch sizes. Pharmaceutical Technology spoke with Joerg Zimmermann, vice-president of Development Service and External Affairs at Vetter, about these challenges and the equipment and facility options to consider.
Read this article in Pharmaceutical Technology's Biologics and Sterile Drug Manufacturing May 2021 eBook.
Jennifer Markarian is manufacturing editor of Pharmaceutical Technology.
Pharmaceutical Technology
eBook: Biologics and Sterile Drug Manufacturing, May 2021
May 2021
Pages: 14–17
When referring to this article, please cite it as J. Markarian, “Filling Small Batches" Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2021).
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.